β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceKey Metrics
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue Per Share | Net Income Per Share | Operating Cash Flow Per Share | Free Cash Flow PerShare | Cash Per Share | Book Value Per Share | Tangible Book Value Per Share | Shareholders Equity Per Share | Interest Debt Per Share | Market Cap | Enterprise Value | P/E Ratio | Price To Sales Ratio | POCF ratio | PFCF Ratio | P/B Ratio | PTB Ratio | EV To Sales | Enterprise Value Over EBITDA | EV To Operating Cash Flow | EV To Free Cash Flow | Earnings Yield | Free Cash Flow Yield | Debt To Equity | Debt To Assets | Net Debt To EBITDA | Current Ratio | Interest Coverage | Income Quality | Dividend Yield | Payout Ratio | Sales General And Administrative To Revenue | R&D To Revenue | Intangibles To Total Assets | CAPEX To Operating Cash Flow | CAPEX To Revenue | CAPEX To Depreciation | Stock Based Compensation To Revenue | Graham Number | ROIC | Return On Tangible Assets | Graham Net-Net | Working Capital | Tangible Asset Value | Net Current Asset Value | Invested Capital | Average Receivables | Average Payables | Average Inventory | Days Sales Outstanding | Days Payables Outstanding | Days Of Inventory On Hand | Receivables Turnover | Payables Turnover | Inventory Turnover | ROE | CAPEX Per Share |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 39.63 | 6.75 | 8.95 | 3.79 | 6.64 | 36.74 | 35.14 | 36.74 | 4.18 | 23911880000 | 23729580000 | 48.53 | 8.26 | 36.6 | 86.51 | 8.91 | 8.91 | 8.2 | 31.9 | 36.32 | 85.85 | 0.02 | 0.01 | 0.11 | 0.08 | -0.25 | 2.79 | 189.97 | 1.33 | 0 | 0.12 | 0 | 0.02 | 0.03 | 0.58 | 0.13 | 2.43 | 0.01 | 74.7 | 0.15 | 0.14 | 1.73 | 987700000 | 2565400000 | 577000000 | 2790700000 | 532250000 | 240850000 | 405850000 | 69.7 | 46.1 | 72.63 | 5.24 | 7.92 | 5.03 | 0.18 | 5.16 |
2023-12 | 39.7 | 7.99 | 10.45 | 5.58 | 11.49 | 38.78 | 37.11 | 38.78 | 4.28 | 26162516000 | 25617616000 | 44.09 | 8.87 | 33.69 | 63.12 | 9.08 | 9.08 | 8.68 | 30.35 | 32.99 | 61.8 | 0.02 | 0.02 | 0.11 | 0.08 | -0.65 | 2.88 | 75.11 | 1.31 | 0 | 0.1 | 0 | 0.02 | 0.03 | 0.47 | 0.12 | 2.64 | 0.01 | 83.47 | 0.17 | 0.16 | 6.82 | 1264600000 | 2757400000 | 987900000 | 2900700000 | 509700000 | 228900000 | 424750000 | 63.35 | 48.6 | 87.15 | 5.76 | 7.51 | 4.19 | 0.21 | 4.87 |
2022-12 | 38.8 | 7.88 | 9.73 | 5.91 | 12.02 | 36.09 | 34.4 | 36.09 | 4.38 | 17510040000 | 16933640000 | 29.89 | 6.07 | 24.19 | 39.85 | 6.52 | 6.52 | 5.87 | 19.07 | 23.39 | 38.54 | 0.03 | 0.03 | 0.12 | 0.09 | -0.65 | 3.7 | 92.91 | 1.24 | 0 | 0.09 | 0 | 0.02 | 0.03 | 0.39 | 0.1 | 2.36 | 0.01 | 79.96 | 0.19 | 0.17 | 7.4 | 1400500000 | 2559200000 | 987600000 | 2788900000 | 498200000 | 223800000 | 396600000 | 64.15 | 44.91 | 86.48 | 5.69 | 8.13 | 4.22 | 0.22 | 3.83 |
2021-12 | 38.06 | 8.9 | 7.85 | 4.44 | 10.25 | 31.39 | 29.6 | 31.39 | 4.47 | 34894344000 | 34457044000 | 52.73 | 12.32 | 59.75 | 105.55 | 14.94 | 14.94 | 12.17 | 38.49 | 59 | 104.23 | 0.02 | 0.01 | 0.14 | 0.1 | -0.49 | 2.93 | 104.49 | 0.88 | 0 | 0.08 | 0 | 0.02 | 0.04 | 0.43 | 0.09 | 2.07 | 0.01 | 79.26 | 0.23 | 0.21 | 4.57 | 1147900000 | 2202500000 | 763600000 | 2407600000 | 437150000 | 222650000 | 349850000 | 63.03 | 51.19 | 83.41 | 5.79 | 7.13 | 4.38 | 0.28 | 3.41 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more key metrics for West Pharmaceutical Services!
Sign up for free or log inπ Join now to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" at no cost